Array-based resequencing for mutations causing familial hypercholesterolemia.

Area of Science:

• Genetics
• Molecular Biology
• Cardiovascular Disease Research

Background:

• Familial Hypercholesterolemia (FH) is a common, inherited disorder affecting cholesterol metabolism.
• Over 1200 mutations in at least three genes are known to cause FH.
• Current genetic testing methods need to be high-throughput, rapid, and affordable for clinical integration.

Purpose of the Study:

• To develop and validate a novel array-based resequencing assay for FH genetic testing.
• To facilitate efficient molecular screening in FH patient populations.

Main Methods:

• Designed a custom DNA resequencing array targeting LDL receptor (LDLR), apolipoprotein B (APOB), and PCSK9 genes.
• Included detection of 290 known insertion/deletion mutations in LDLR.
• Validated array performance on 35 known samples and a blinded study of 125 FH patients.

Main Results:

• The FH array demonstrated high accuracy with 99.99% agreement with capillary sequencing.
• Achieved an average call rate of 98.45% across the array.
• Detected mutations in 77.5% of definite and 52.9% of probable FH cases in a blinded screening.

Conclusions:

• The high-throughput FH resequencing array accurately detects mutations in key FH-related genes.
• This technology facilitates efficient, large-scale genetic screening for heterogeneous FH populations.
• Enables better integration of molecular diagnostics into clinical practice for FH management.